BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun T, Kwong CHT, Gao C, Wei J, Yue L, Zhang J, Ye RD, Wang R. Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine. Theranostics 2020;10:10106-19. [PMID: 32929337 DOI: 10.7150/thno.48448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Lin J, Song X, Yin H, Song N, Wang Y, Li Z, Luo F, Tan H, He X, Li J. Citicoline–liposome/polyurethane composite scaffolds regulate the inflammatory response of microglia to promote nerve regeneration. J Mater Sci 2022;57:2073-88. [DOI: 10.1007/s10853-021-06628-0] [Reference Citation Analysis]
2 Sun L, Ouyang J, Zeng F, Wu S. An AIEgen-based oral-administration nanosystem for detection and therapy of ulcerative colitis via 3D-MSOT/NIR-II fluorescent imaging and inhibiting NLRP3 inflammasome. Biomaterials 2022;283:121468. [DOI: 10.1016/j.biomaterials.2022.121468] [Reference Citation Analysis]
3 Zhang H, He Q, Wang J, Wang Y, Xuan X, Sui M, Zhang Z, Hou L. Biomimetic Micelles to Accurately Regulate the Inflammatory Microenvironment for Glomerulonephritis Treatment. Pharmacol Res 2022;:106263. [PMID: 35597383 DOI: 10.1016/j.phrs.2022.106263] [Reference Citation Analysis]
4 Zhang C, Li J, Xiao M, Wang D, Qu Y, Zou L, Zheng C, Zhang J. Oral colon-targeted mucoadhesive micelles with enzyme-responsive controlled release of curcumin for ulcerative colitis therapy. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.03.110] [Reference Citation Analysis]
5 Li X, Fang S, Yu Y, Yang H, Rao Y, Hong D, Lu C, Yu M, Lu X, Yu C, Zhao Q. Oral administration of inflammatory microenvironment-responsive carrier-free infliximab nanocomplex for the targeted treatment of inflammatory bowel disease. Chemical Engineering Journal 2022;445:136438. [DOI: 10.1016/j.cej.2022.136438] [Reference Citation Analysis]
6 Teo KYW, Sevencan C, Cheow YA, Zhang S, Leong DT, Toh WS. Macrophage Polarization as a Facile Strategy to Enhance Efficacy of Macrophage Membrane‐Coated Nanoparticles in Osteoarthritis. Small Science. [DOI: 10.1002/smsc.202100116] [Reference Citation Analysis]
7 Tan Q, He L, Meng X, Wang W, Pan H, Yin W, Zhu T, Huang X, Shan H. Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. J Nanobiotechnology 2021;19:173. [PMID: 34112203 DOI: 10.1186/s12951-021-00926-0] [Reference Citation Analysis]
8 Xiao H, Li H, Wen Y, Jiang D, Zhu S, He X, Xiong Q, Gao J, Hou S, Huang S, He L, Liang J. Tremella fuciformis polysaccharides ameliorated ulcerative colitis via inhibiting inflammation and enhancing intestinal epithelial barrier function. Int J Biol Macromol 2021;180:633-42. [PMID: 33744251 DOI: 10.1016/j.ijbiomac.2021.03.083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yan X, Pan Q, Xin H, Chen Y, Ping Y. Genome-editing prodrug: Targeted delivery and conditional stabilization of CRISPR-Cas9 for precision therapy of inflammatory disease. Sci Adv 2021;7:eabj0624. [PMID: 34878850 DOI: 10.1126/sciadv.abj0624] [Reference Citation Analysis]
10 Chen F, Liu Q, Xiong Y, Xu L. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease. Int J Nanomedicine 2021;16:4225-37. [PMID: 34188471 DOI: 10.2147/IJN.S310952] [Reference Citation Analysis]
11 Soni SS, Alsasa A, Rodell CB. Applications of Macrocyclic Host Molecules in Immune Modulation and Therapeutic Delivery. Front Chem 2021;9:658548. [PMID: 33889565 DOI: 10.3389/fchem.2021.658548] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang L, Gui S, Xu Y, Zeng J, Wang J, Chen Q, Su L, Wang Z, Deng R, Chu F, Liu W, Jin X, Lu X. Colon tissue-accumulating mesoporous carbon nanoparticles loaded with Musca domestica cecropin for ulcerative colitis therapy. Theranostics 2021;11:3417-38. [PMID: 33537095 DOI: 10.7150/thno.53105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Jia L, Zhang P, Sun H, Dai Y, Liang S, Bai X, Feng L. Optimization of Nanoparticles for Smart Drug Delivery: A Review. Nanomaterials (Basel) 2021;11:2790. [PMID: 34835553 DOI: 10.3390/nano11112790] [Reference Citation Analysis]
14 Xu WJ, Cai JX, Li YJ, Wu JY, Xiang D. Recent progress of macrophage vesicle-based drug delivery systems. Drug Deliv Transl Res 2022. [PMID: 34984664 DOI: 10.1007/s13346-021-01110-5] [Reference Citation Analysis]
15 Wang YX, Lin C, Cui LJ, Deng TZ, Li QM, Chen FY, Miao XP. Mechanism of M2 macrophage-derived extracellular vesicles carrying lncRNA MEG3 in inflammatory responses in ulcerative colitis. Bioengineered 2021;12:12722-39. [PMID: 34895044 DOI: 10.1080/21655979.2021.2010368] [Reference Citation Analysis]
16 Shi C, Dawulieti J, Shi F, Yang C, Qin Q, Shi T, Wang L, Hu H, Sun M, Ren L, Chen F, Zhao Y, Liu F, Li M, Mu L, Liu D, Shao D, Leong KW, She J. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease. Sci Adv 2022;8:eabj2372. [PMID: 35089791 DOI: 10.1126/sciadv.abj2372] [Reference Citation Analysis]
17 Ding Y, Li Y, Sun Z, Han X, Chen Y, Ge Y, Mao Z, Wang W. Cell-derived extracellular vesicles and membranes for tissue repair. J Nanobiotechnology 2021;19:368. [PMID: 34789267 DOI: 10.1186/s12951-021-01113-x] [Reference Citation Analysis]